Advances in the development of novel factor Xa inhibitors: a patent review
AN Khadse, MK Sharma, PR Murumkar… - Mini Reviews in …, 2018 - ingentaconnect.com
Development of new anticoagulants has been in constant demand throughout the world due
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …
Advances in the Development of Novel Factor Xa Inhibitors: A Patent Review
AN Khadse, MK Sharma… - Mini reviews in …, 2018 - pubmed.ncbi.nlm.nih.gov
Development of new anticoagulants has been in constant demand throughout the world due
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …
Advances in the Development of Novel Factor Xa Inhibitors: A Patent Review.
AN Khadse, MK Sharma, PR Murumkar… - Mini Reviews in …, 2018 - europepmc.org
Development of new anticoagulants has been in constant demand throughout the world due
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …
Advances in the Development of Novel Factor Xa Inhibitors: A Patent Review
AN Khadse, MK Sharma, PR Murumkar… - Mini-Reviews in …, 2018 - elibrary.ru
Development of new anticoagulants has been in constant demand throughout the world due
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …
to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa) …